Consolidated Statements of Profit or Loss and Other Comprehensive Income

(In thousands of USD, except per share amounts)

For the Nine-Month Period Ended
September 30,

For the Three-Month Period
Ended
September 30,

For the Year
ended December 31,

2018

2018

2019

2018

(Unaudited)

(Unaudited)

 (Unaudited)

 (Unaudited)

Revenues

3,395

5,093

1,672

2,243

5,100

Cost of revenues

2,216

3,183

1,092

1,224

3,594

Cost of revenues - amortization of intangible

579

579

193

193

772

Total cost of revenues

2,795

3,762

1,285

1,417

4,366

Gross profit

600

1,331

387

826

734

Research and development expenses, net

6,671

6,557

2,129

2,083

8,623

Sales and marketing expenses

3,040

4,088

1,167

1,217

4,259

General and administrative expenses

2,249

2,389

685

799

3,002

Operating loss

(11,360)

(11,703)

(3,594)

(3,273)

(15,150)

Finance income

46

6,923

31

100

54

Finance expense

207

2,192

65

1,135

(*)

392

Total comprehensive loss

(11,521)

(6,972)

(3,628)

(4,308)

(15,488)

Basic loss per share

(0.13)

(0.04)

(0.04)

(0.02)

(0.17)

Basic loss per American Depositary Shares
   (after the change in the ADS ratio)

(6.40)

(2.08)

(1.90)

(1.21)

(8.40)

 (*) The Finance expenses are mainly attributed to the offerings we made during the nine month period ended
September 30, 2019, resulting in issuance expenses of approximately $469,000 that were recognized as finance
expenses, and expenses due to changes in the fair value of convertible notes and warrants of approximately
$495,000.